Monitoring sequential treatment of actinic keratosis using post-processed images: Ingenol mebutate and cryosurgery
Academic Article
Publication Date:
2019
abstract:
Actinic keratoses (AKs) are atypical proliferations of epithelial skin cells. The risk of progression from AK lesions to SCC is well documented.1 Ingenol Mebutate (IM), a derivative of the plant Euphorbia Peplus, has been used in AK treatment2 both for lesion-directed and field treatment. Cryosurgery is commonly used for lesion-directed treatment. Both treatments are associated with local skin reaction (LSR). This article is protected by copyright. All rights reserved.
Iris type:
1.1 Articolo in rivista
Keywords:
3D photography; actinic keratosis; cryosurgery; cryotherapy; field cancerization; ingenol mebutate; medical photography; non invasive imaging technology; photography; RBX technology; treatment
List of contributors:
Pasquali, P; Segurado-Miravalles, G; Baldi, A; Vincenzi, B; Bizzi, S; Bonavenia, R; Gonzalez, S
Published in: